Scope
Description
Medicines Discovery Catapult (MDC) intends to award a contract for the purchase of a Xenium single-cell spatial transcriptomics/proteomics instrument to 10X Genomics. The purchase of the equipment will be at a value of £220,000, with the possibility for four twelve month extension of warranty periods.
Contract 1
Supplier
Contract value
- £344,000 excluding VAT
- £412,800 including VAT
Above the relevant threshold
Award decision date
8 December 2025
Standstill period
- End: 17 December 2025
- 8 working days
Earliest date the contract will be signed
18 December 2025
Contract dates (estimated)
- 18 December 2025 to 17 December 2026
- Possible extension to 17 December 2030
- 5 years
Description of possible extension:
The contract may be extended to purchase four 12 month warranty extensions.
Main procurement category
Goods
Options
The right to additional purchases while the contract is valid.
The contract may be extended to purchase four 12 month warranty extensions.
CPV classifications
- 38000000 - Laboratory, optical and precision equipments (excl. glasses)
Contract locations
- UK - United Kingdom
Procedure
Procedure type
Direct award
Supplier
10x Genomics Inc
- Public Procurement Organisation Number: PBMJ-4568-WMPX
6230 Stoneridge Mall Road
Pleasanton
CA 94588-3260
United States
Email: tenders@10xgenomics.com
Website: https://www.10xgenomics.com/
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Contract 1
Contracting authority
MEDICINES DISCOVERY CATAPULT LIMITED
- Companies House: 09928547
- Public Procurement Organisation Number: PJPQ-6911-DQYY
Block 35g, Mereside Alderley Park
Macclesfield
SK10 4ZF
United Kingdom
Region: UKD62 - Cheshire East
Organisation type: Public authority - sub-central government